1.
Balhara, MBBS, MD, DNB, MNAMS YPS. Time to include buprenorphine-naloxone combination in the WHO model list of essential medicines. J of Opioid Management [Internet]. 2013 Jul. 1 [cited 2024 Nov. 22];9(4):237. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/566